Schedule of warrant activity (Details) - Warrant [Member] |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
$ / shares
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Number of warrants, balance, beginning of year | 243,323,017 |
| Weighted average exercise price, beginning of year | $ / shares | $ 0.021 |
| Weighted average life exercised (in years) | 1 year 3 months 18 days |
| Weighted average grant date fair value, beginning of period | $ | $ 1,963,079 |
| Number of warrants, expired | |
| Number of warrants, balance, end of period | 243,323,017 |
| Weighted average exercise price, ending of year | $ / shares | $ 0.021 |
| Weighted average life exercised (in years) | 9 months 18 days |
| Weighted average grant date fair value, end of period | $ | $ 1,963,079 |
| X | ||||||||||
- Definition The element represents Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition The element represents Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Grant Date Fair Value No definition available.
|
| X | ||||||||||
- Definition The element represents Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Issued Weighted Average Remaining Excerisable Contractual End Term2 No definition available.
|
| X | ||||||||||
- Definition The element represents Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Issued Weighted Average Remaining Excerisable Contractual Term2 No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|